眼科治疗公司

最新新闻

• 评级变动
  William Blair Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Announces Target Price $9.32
  \u5e02\u573a\u8d44\u8baf · 2026/4/29
• 评级变动
  RBC Capital Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• William Blair Maintains Ocular Therapeutix(OCUL.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/26
• 评级变动
  TD Cowen Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• Needham Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $18
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  Needham Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Cuts Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/2/20
• 评级变动
  A Quick Look at Today's Ratings for Ocular Therapeutix(OCUL.US), With a Forecast Between $20 to $31
  \u5e02\u573a\u8d44\u8baf · 2026/2/18
• 评级变动
  A Quick Look at Today's Ratings for Ocular Therapeutix(OCUL.US), With a Forecast Between $18 to $31
  \u5e02\u573a\u8d44\u8baf · 2026/6/19
• 评级变动
  Chardan Capital Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Raises Target Price to $23
  \u5e02\u573a\u8d44\u8baf · 2026/6/25
• 评级变动
  Baird Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Raises Target Price to $30
  \u5e02\u573a\u8d44\u8baf · 2026/6/18
• 评级变动
  Analysts Conflicted on These Healthcare Names: Ocular Therapeutix (OCUL) and Aardvark Therapeutics, Inc. (AARD)
  TipRanks · 2026/3/2
• Piper Sandler Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $31
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  H.C. Wainwright Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $21
  \u5e02\u573a\u8d44\u8baf · 2026/4/30
• 评级变动
  Chardan Capital Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $21
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• H.C. Wainwright Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  A Quick Look at Today's Ratings for Ocular Therapeutix(OCUL.US), With a Forecast Between $18 to $30
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• 评级变动
  Analysts Are Bullish on These Healthcare Stocks: Prime Medicine, Inc. (PRME), Ocular Therapeutix (OCUL)
  TipRanks · 2026/6/19
• 评级变动
  Clear Street Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $28
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• BofA Securities Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $27
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  BofA Securities Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Raises Target Price to $27
  \u5e02\u573a\u8d44\u8baf · 2026/3/3

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。